Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
389.22
+3.93 (1.02%)
Jan 21, 2025, 4:00 PM EST - Market closed
Elevance Health Revenue
Elevance Health had revenue of $45.15B in the quarter ending September 30, 2024, with 5.36% growth. This brings the company's revenue in the last twelve months to $174.02B, up 3.20% year-over-year. In the year 2023, Elevance Health had annual revenue of $171.34B with 9.41% growth.
Revenue (ttm)
$174.02B
Revenue Growth
+3.20%
P/S Ratio
0.52
Revenue / Employee
$1,658,866
Employees
104,900
Market Cap
90.27B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 171.34B | 14.74B | 9.41% |
Dec 31, 2022 | 156.60B | 17.96B | 12.95% |
Dec 31, 2021 | 138.64B | 16.78B | 13.76% |
Dec 31, 2020 | 121.87B | 17.66B | 16.94% |
Dec 31, 2019 | 104.21B | 12.12B | 13.16% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 87.70B |
Merck & Co. | 63.17B |
AbbVie | 55.53B |
AstraZeneca | 51.21B |
Novartis AG | 49.94B |
Thermo Fisher Scientific | 42.37B |
Abbott Laboratories | 41.22B |
ELV News
- 8 hours ago - Mark Farrah Associates Delves into Acquisition Impacts Utilizing New Tools - Business Wire
- 12 days ago - Elevance Health to Hold Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2024 Results on January 23, 2025 - Business Wire
- 18 days ago - My Top 15 High Growth Dividend Stocks For January 2025 - Seeking Alpha
- 26 days ago - Elevance Health Is An Undervalued Healthcare Juggernaut - Seeking Alpha
- 5 weeks ago - Santa's Stunning Stocking Surprises: 5 High Yield Blue-Chip Bargains For 2025 - Seeking Alpha
- 5 weeks ago - Robbins LLP Informs Elevance Health Inc. Stockholders that it is Investigating the Officers and Directors of ELV to Determine if They Breached Fiduciary Duties Owed to Shareholders - GlobeNewsWire
- 5 weeks ago - Health care stocks fall as lawmakers, patients push for changes to their business models - CNBC
- 5 weeks ago - Health insurer stocks fall as WSJ says lawmakers set to break up pharmacy-benefit managers - Reuters